On April 17, 2018, the Institute for Patient Access convened the third annual National Policy and Advocacy Summit on Biologics and Biosimilars in Washington, DC. Patients, government representatives, physicians and advocates came together for the day-long event, which celebrated innovation, highlighted the power of biologic and biosimilar treatments, and examined the barriers to patient access.
The event was co-sponsored by the Alliance for Patient Access and the Biologics Prescribers Collaborative.
A series of panels, onstage interviews and featured speakers touched on biosimilar uptake, education efforts, health plan barriers, therapeutic switching and the importance of the physician-patient relationship.
